Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Pacini

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Thyroid : Official Journal of the American Thyroid Association|July 29, 2020
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid NodulesFabio Maino, Annalisa Bufano, Gilda Dalmazio, et al.
The Journal of Clinical Endocrinology and Metabolism|April 20, 2018
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNACFabio Maino, Raffaella Forleo, Martina Martinelli, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2007
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up studyRossella Elisei, Barbara Cosci, Cristina Romei, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancerMarco Capezzone, Silvia Cantara, Stefania Marchisotta, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genesRossella Elisei, Agnese Vivaldi, Laura Agate, et al.
European Journal of Endocrinology|February 7, 2004
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspectiveMartin Schlumberger, Gertrud Berg, Ohad Cohen, et al.
The American Journal of Pathology|January 12, 2002
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaFulvio Basolo, Riccardo Giannini, Carmen Monaco, et al.
Thyroid : Official Journal of the American Thyroid Association|May 28, 2009
Medullary thyroid cancer: management guidelines of the American Thyroid Association, Richard T Kloos, Charis Eng, et al.
European Journal of Endocrinology|November 2, 2005
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportFurio Pacini, Martin Schlumberger, Clive Harmer, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2005
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behaviorRosa Paula Biscolla, Clara Ugolini, Mariangela Sculli, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Thyroid : Official Journal of the American Thyroid Association|July 29, 2020
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid NodulesFabio Maino, Annalisa Bufano, Gilda Dalmazio, et al.
The Journal of Clinical Endocrinology and Metabolism|April 20, 2018
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNACFabio Maino, Raffaella Forleo, Martina Martinelli, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2007
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up studyRossella Elisei, Barbara Cosci, Cristina Romei, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancerMarco Capezzone, Silvia Cantara, Stefania Marchisotta, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genesRossella Elisei, Agnese Vivaldi, Laura Agate, et al.
European Journal of Endocrinology|February 7, 2004
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspectiveMartin Schlumberger, Gertrud Berg, Ohad Cohen, et al.
The American Journal of Pathology|January 12, 2002
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaFulvio Basolo, Riccardo Giannini, Carmen Monaco, et al.
Thyroid : Official Journal of the American Thyroid Association|May 28, 2009
Medullary thyroid cancer: management guidelines of the American Thyroid Association, Richard T Kloos, Charis Eng, et al.
European Journal of Endocrinology|November 2, 2005
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportFurio Pacini, Martin Schlumberger, Clive Harmer, et al.
Thyroid : Official Journal of the American Thyroid Association|January 27, 2005
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behaviorRosa Paula Biscolla, Clara Ugolini, Mariangela Sculli, et al.
Pageof 15